Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 19, 2018

Amneal Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

Nov 21, 2018

Amneal to Present at the 30th Annual Piper Jaffray Healthcare Conference

Nov 12, 2018

Amneal Completes Transition Agreement With Lannett Company To Begin Commercialization Of Levothyroxine On December 1st

Nov 07, 2018

Amneal Announces Solid Third Quarter 2018 Financial Results

Oct 25, 2018

Expiration Dates for Certain Lots of Generic Adrenaclick® Epinephrine Injection, USP Auto-Injector Extended to 20 Months

Oct 24, 2018

Amneal Announces Issuance of New Patent for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa

Oct 23, 2018

Amneal Announces Approval and Launch of Clobazam Tablets and Clobazam Oral Suspension

Oct 19, 2018

Amneal Announces Approval of Carmustine for Injection USP, 100 mg/vial - Preparing for Launch

Oct 19, 2018

Amneal Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP

Sep 24, 2018

Amneal to Present at the Cantor Fitzgerald Global Healthcare Conference

Sep 21, 2018

Amneal to Report Third Quarter 2018 Results on November 7, 2018

Sep 12, 2018

Amneal Announces FDA Approval and Launch of Generic Chlorpromazine Hydrochloride Tablets USP and Approval of Methylergonovine Maleate Tablets USP

Aug 31, 2018

Amneal to Present at Upcoming Investor Conferences

Aug 31, 2018

Amneal Announces Partnership with American Regent on Generic Makena® and Progress on its Business Plan with Additional ANDA Approvals and Launches

Aug 20, 2018

Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine

Aug 09, 2018

Amneal Announces Solid Second Quarter 2018 Financial Results

Jul 23, 2018

Amneal Announces FDA Approval and Launch of Generic Potassium Chloride Oral Solution

Jun 29, 2018

Amneal to Report Second Quarter 2018 Results on August 9, 2018

Jun 29, 2018

Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig® (zolmitriptan) Nasal Spray

Jun 20, 2018

Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary®

Jun 06, 2018

Amneal to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

May 30, 2018

Amneal Announces FDA Approval of Cyclophosphamide for Injection USP, Generic to Cytoxan®

May 18, 2018

Amneal Pharmaceuticals Celebrates Combination by Ringing Opening Bell at New York Stock Exchange

May 17, 2018

Amneal Announces FDA Approval and Launch of Generic Welchol® (Colesevelam HCl) Tablets, 625 mg

May 15, 2018

Amneal Introduces First Generic for Mephyton® (Phytonadione) Tablets, 5mg

May 14, 2018

Amneal to Present at the UBS Global Healthcare Conference

May 11, 2018

Amneal Announces Actions to Streamline Operations and Capture Cost Synergies

May 07, 2018

Amneal Initiates Phase 3 Study for IPX203, an Investigational Extended-Release Formulation of Carbidopa-Levodopa (CD-LD) in Advanced Parkinson's Disease Patients

May 07, 2018

Amneal and Impax Complete Business Combination

May 02, 2018

Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP

Apr 27, 2018

Amneal And Impax Receive FTC Clearance For Business Combination

Apr 06, 2018

Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)

Mar 27, 2018

Impax Shareholders Approve Proposed Business Combination with Amneal

Mar 14, 2018

Amneal Gains Approval for Erythromycin Tablets, USP

Mar 12, 2018

Amneal Launches Generic for Gabitril®

Mar 07, 2018

Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference

Mar 07, 2018

Joint Amneal-Impax Lender Presentation

Mar 02, 2018

Amneal 4th Quarter & Full Year 2017 Quarterly Financial Report

Mar 01, 2018

Amneal Launches Generic for Tamiflu® Oral Suspension

Mar 01, 2018

Impax Reports Fourth Quarter and Full Year 2017 Results

Feb 21, 2018

Amneal Introduces Generic for Namenda XR®

Feb 20, 2018

Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets

Feb 06, 2018

Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations

Feb 05, 2018

Amneal Launches AB-Rated Generic for Concerta®

Feb 01, 2018

Amneal Introduces Isotretinoin Capsules

Jan 23, 2018

PSEG Long Island Presents Amneal Facility with Energy-Efficiency Rebates

Jan 18, 2018

Amneal Biosciences Launches Budesonide Capsules

Jan 16, 2018

Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018

Jan 04, 2018

Amneal Biosciences Introduces Busulfan Injection, Generic for Busulfex®

Jan 03, 2018

Amneal and Impax to Present at J.P. Morgan Healthcare Conference

Jan 03, 2018

Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.19.0.1